肠系膜下动脉通畅性对腹主动脉瘤腔内修复术后7年结局的影响
该回顾性队列研究纳入336例腹主动脉瘤腔内修复术(EVAR)患者,按术前肠系膜下动脉(IMA)是否通畅分组,经倾向评分匹配后每组86例,中位随访56个月。通畅组出院时II型内漏发生率50%高于闭塞组19%(p<0.001),7年免于动脉瘤囊扩张率69%低于闭塞组94%(p<0.001),免于再干预率74%低于闭塞组90%(p=0.007),两组死亡率无显著差异。作者认为IMA通畅可能影响晚期再干预和囊扩张,术前评估及栓塞IMA可能是改善晚期EVAR结局的重要因素。
要点
- IMA通畅组出院时II型内漏发生率50%,闭塞组19%(p<0.001)。
- 7年免于囊扩张伴II型内漏:闭塞组94% vs 通畅组69%(p<0.001)。
- 7年免于再干预:闭塞组90% vs 通畅组74%(p=0.007);死亡率无显著差异。
核心结论
- IMA通畅可能影响晚期再干预和动脉瘤囊扩张,但对死亡率无显著影响。
- 作者认为术前评估及栓塞IMA可能是改善晚期EVAR结局的重要因素。
研究设计与样本
- 回顾性队列研究,纳入2006年1月至2019年12月在本机构因真性腹主动脉瘤行EVAR的556例,筛选后共336例入组。
- 按术前IMA状态分为通畅组和闭塞组,使用倾向评分匹配数据比较晚期结局,匹配后每组86例。
- 中位随访56个月(四分位距32-94个月)。
主要发现
- 出院时II型内漏发生率通畅组50% vs 闭塞组19%(p<0.001)。
- 来自IMA和腰动脉的II型内漏在通畅组显著高于闭塞组(p<0.001和p=0.002)。
- 7年免于囊扩张伴II型内漏率闭塞组94% vs 通畅组69%(p<0.001)。
- 7年免于再干预率闭塞组90% vs 通畅组74%(p=0.007)。
- 腹主动脉瘤相关死亡和全因死亡率两组无显著差异(p=0.32和p=0.34)。
临床怎么用
- 作者认为术前评估及栓塞IMA可能是改善晚期EVAR结局的重要因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The impact of preoperative patent inferior mesenteric artery (IMA) on late outcomes following endovascular aneurysm repair (EVAR) remains unclear. This study aimed to investigate the specific influence of IMA patency on 7-year outcomes after EVAR. MATERIALS AND METHODS: In this retrospective cohort study, 556 EVARs performed for true abdominal aortic aneurysm cases between January 2006 and December 2019 at our institution were reviewed. Endovascular aneurysm repairs performed using a commercially available device with no type I or type III endoleak (EL) during follow-up and with follow-up ≥12 months were included. A total of 336 patients were enrolled in this study. The cohort was divided into the patent IMA group and the occluded IMA group according to preoperative IMA status. The late outcomes, including aneurysm sac enlargement, reintervention, and mortality rates, were compared between both groups using propensity-score-matched data. RESULTS: After propensity score matching, 86 patients were included in each group. The median follow-up period was 56 months (interquartile range: 32-94 months). The incidence of type II EL at discharge was 50% in the patent IMA group and 19% in the occluded IMA group (p<0.001). The type II EL from IMA and lumbar arteries was significantly higher in the patent IMA group than in the occluded IMA group (p<0.001 and p=0.002). The rate of freedom from aneurysm sac enlargement with type II EL was significantly higher in the occluded IMA group than in the patent IMA group (94% vs 69% at 7 years; p<0.001). The rate of freedom from reintervention was significantly higher in the occluded IMA group than in the patent IMA group (90% vs 74% at 7 years; p=0.007). Abdominal aortic aneurysm-related death and all-cause mortality did not significantly differ between groups (p=0.32 and p=0.34). CONCLUSIONS: Inferior mesenteric artery patency could affect late reintervention and aneurysm sac enlargement but did not have a significant impact on mortality. Preoperative assessment and embolization of IMA might be an important factor for improvement in late EVAR outcomes. CLINICAL IMPACT: The preoperative patency of the inferior mesenteric artery was significantly associated with a higher incidence of sac enlargement and reintervention with type II endoleak following endovascular aneurysm repair, even after adjustment for patient background. Preoperative assessment and embolization of inferior mesenteric artery might be an important factor for improvement in late EVAR outcomes.
引用
- Ide T, Shimamura K, Kuratani T, et al. Impact of the Patency of Inferior Mesenteric Artery on 7-Year Outcomes After Endovascular Aneurysm Repair. J Endovasc Ther. 2022. PMID: 36120997. doi:10.1177/15266028221121748
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。